GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
TECHSellZACKSHold
R500#465 today
$144.74
-1.87% today · -4.10% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- GILD −1.87% on the last session vs SPY +0.74%: −2.6 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $179.5B
- Held by institutions
- 92.2%
- Short interest
- 1.5%
- 52-week range
- 112.41–157.29
- Analyst mean target
- —
- Next earnings
- Oct 29 AMC
- Forward P/E
- 14.6
Recent events
Earnings ▲
2Q2026 results: EPS −$6.75 vs −$7.25 expected beat +$0.50 (+6.9%); next session -2.6% (-2.4 vs SPY)Earnings ▲
1Q2026 results: EPS $2.03 vs $1.91 expected beat +$0.12 (+6.2%); revenue $7.0B; next session -2.0% (-2.9 vs SPY)Earnings ▲
4Q2025 results: EPS $1.86 vs $1.81 expected beat +$0.05 (+2.8%); revenue $7.9B; next session +5.8% (+5.8 vs SPY)Earnings ▲
3Q2025 results: EPS $2.47 vs $2.14 expected beat +$0.33 (+15.7%); revenue $7.8B; next session +1.1% (+0.8 vs SPY)